Thomas Stephen Basil sold CLYM
February 26, 2026 · Form 4 insider transaction
Thomas Stephen Basil sold 16,313 shares of Climb Bio Inc at $7.01 per share, a transaction worth $114.3K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
16,313
Price
$7.01
Total value
$114.3K
InsiderThomas Stephen Basil
RoleDirector
CompanyClimb Bio Inc (CLYM)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 26, 2026
Filing dateFebruary 27, 2026
Shares owned after154,657
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 14, 2025.; The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.0000 to $7.0400, inclusive.